SII commences shipments of malaria vaccine ‘R21/Matrix-M’ to Africa

Serum Institute of India (SII) begins sending the ‘R21/Matrix-M’ malaria vaccine to Africa to aid in combatting the disease. Initially, 43,200 doses have been dispatched to the Central African Republic. A total of 1,63,800 doses have been allocated for the region. Developed with University of Oxford and Novavax, the vaccine received WHO approval in October. The initiative is praised as a significant step in the fight against malaria.

Get NewsPepper Short News App from Play Store